Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 8/20 | 0.62 |
| ▸ | RPTOR | Q8N122 | 8/20 | 0.62 |
| ▸ | MLST8 | Q9BVC4 | 8/20 | 0.62 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 3/20 | 0.36 |
| ▸ | TACR3 | P29371 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | FASN | P49327 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22693151 | 0.88 | MTOR (0.60) | MTORRPTORMLST8GRM5NAMPT | |
| SCHEMBL20133739 | 0.87 | MTOR (0.78) | MTORRPTORMLST8GRM5NAMPT | |
| SCHEMBL20133751 | 0.86 | MTOR (0.72) | MTORRPTORMLST8GRM5NAMPT | |
| SCHEMBL20150218 | 0.84 | MTOR (0.74) | MTORRPTORMLST8GRM5NAMPT | |
| SCHEMBL22693146 | 0.83 | MTOR (0.73) | MTORRPTORMLST8GRM5NAMPT | |
| SCHEMBL22693096 | 0.83 | MTOR (0.43) | MTORRPTORMLST8 | |
| SCHEMBL21360385 | 0.83 | MTOR (0.72) | MTORRPTORMLST8GRM5NAMPT | |
| SCHEMBL20149902 | 0.83 | MTOR (0.72) | MTORRPTORMLST8GRM5NAMPT | |
| SCHEMBL22693225 | 0.82 | MTOR (0.54) | MTORRPTORMLST8KDM4ELMNA | |
| SCHEMBL21360383 | 0.81 | MTOR (0.72) | MTORRPTORMLST8GRM5NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | MTOR, RICTOR, RPTOR | MTOR 1/4885RPTOR 3/4885MLST8 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.